Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Hyaluronidase for Sclerodactyly in Systemic Sclerosis
NCT07916324Phase 2Not yet recruiting
- Sponsor
- Stanford University
- Start
- Dec 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of hyaluronidase in sclerodactyly, systemic sclerosis (SSc), sponsored by Stanford University. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
hyaluronidase
03
Conditions
sclerodactylysystemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07916324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916324.